Other systemic inflammation‐related blood biomarkers and specific cytokines (such as C‐reactive protein, interleukins IL‐6, and IL‐8) are also commonly measured and used to predict clinical outcomes for patients with cancer.19, 34, 35, 36. This evidence concerns the gene CXCL8 and cancer.